Related Experiment Videos
[Childhood-onset systemic lupus erythematosus]
B Bader-Meunier1, P Quartier, G Deschênes
1Service de pédiatrie générale, hôpital de Bicêtre, 78, rue du Général-Leclerc, 94276 Le Kremlin-Bicêtre, France. brigitte.bader-meunier@bct.ap-hop-paris.fr
Summary
Systemic Lupus Erythematosus (SLE) in children presents unique challenges with more severe organ involvement. While outcomes have improved, childhood SLE still carries significant morbidity.
Area of Science:
- Autoimmune diseases
- Pediatric rheumatology
- Immunology
Context:
- Systemic Lupus Erythematosus (SLE) is a complex autoimmune condition.
- Pediatric SLE (pSLE) accounts for 10-17% of all lupus cases.
- Childhood-onset SLE often exhibits more severe organ manifestations compared to adult-onset disease.
Purpose:
- To summarize the current understanding of childhood SLE.
- To highlight the challenges in etiology, pathogenesis, and treatment of pSLE.
- To underscore the persistent high morbidity despite improved outcomes.
Summary:
- Systemic Lupus Erythematosus (SLE) is a significant autoimmune disease with a notable prevalence in pediatric populations.
- Children with SLE frequently experience more severe organ involvement than adults.
- Recent advancements have improved the prognosis for childhood SLE, yet substantial morbidity persists.
Impact:
- Improved understanding of pediatric SLE epidemiology and clinical presentation.
- Highlights the need for continued research into effective treatments for childhood SLE.
- Emphasizes the ongoing challenge of managing morbidity in pediatric autoimmune diseases.